Parkman Healthcare Partners LLC Silence Therapeutics PLC Transaction History
Parkman Healthcare Partners LLC
- $770 Million
- Q1 2025
A detailed history of Parkman Healthcare Partners LLC transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Parkman Healthcare Partners LLC holds 401,746 shares of SLN stock, worth $2.25 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
401,746
Previous 491,080
18.19%
Holding current value
$2.25 Million
Previous $3.38 Million
66.49%
% of portfolio
0.15%
Previous 0.49%
Shares
12 transactions
Others Institutions Holding SLN
# of Institutions
62Shares Held
21.8MCall Options Held
1.3KPut Options Held
2.6K-
Tcg Crossover Management, LLC Palo Alto, CA3.03MShares$17 Million2.06% of portfolio
-
Siren, L.L.C. New York, NY2.91MShares$16.3 Million0.87% of portfolio
-
Redmile Group, LLC San Francisco, CA2.21MShares$12.4 Million0.66% of portfolio
-
Morgan Stanley New York, NY2MShares$11.2 Million0.0% of portfolio
-
Lombard Odier Asset Management (Usa) Corp New York, NY1.85MShares$10.3 Million0.44% of portfolio
About Silence Therapeutics plc
- Ticker SLN
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,888,400
- Market Cap $201M
- Description
- Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...